Kate D retweeted
Our genes are free and so is our data! Glad to see MGL is finally willing to collaborate to help patients get answers. #datasharing #ClinVar #GCchat #BRCA #Ambry
genomeweb.com/molecular-diag…
Kate D retweeted
Breaking: Nearly 3,500 public health pros are signaling their support for Dr. Anthony Fauci and are denouncing the White House attacks on him. Thank you @gregggonsalves for cowriting and circulating this with us:
ow.ly/tqWk50AFsRF
Kate D retweeted
Monalyn Umali Salvador, MS, CGC explains how our study of the first 700 patients tested with TumorNext-Lynch demonstrates the value of paired/tumor germline testing. Read the study to learn more: ow.ly/uYep30nxZyM
Kate D retweeted
Ambry and the National Ovarian Cancer Coalition are partnering in support of Ovarian Cancer Awareness month, to host a Facebook Live on September 20th at 5 pm EST / 2 pm PST. Join us on Facebook to learn more about myths related to genetic testing for hereditary ovarian cancer!
Kate D retweeted
Today we announced the first ever Genetic Counselor Awareness Day to be held on Nov 9. https://teapawt.net/t.co/kwu8nBXb5A #IAmAGeneticCounselor #NSGC17
Kate D retweeted
Ambry is presenting exciting new research at #NSGC17. View our poster info & presentation times here: ow.ly/kXEy30eJsyj
Kate D retweeted
If your 1st degree relatives have known #BRCA1 / #BRCA2 mutations, you may be at increased risk for #prostatecancer. ow.ly/EihV30eN77j
Kate D retweeted
We are hiring at least 3 more genetic counselors in cancer, prenatal, and otolarygology! Come join our growing team! #WhyIowa @uihealthcare
Kate D retweeted
Layla Shahmirzadi: “Our market research shows that 52% of consumers are interested in genetic testing”. #ACMGmtg17
Kate D retweeted
Come view our research poster at #ACMGmtg17 to learn how candidate gene analysis increases diagnostic rate for individuals w/ #epilepsy:
Kate D retweeted
Our recent study showed that DTC #genetictesting reports up to 40% false positives. Visit poster 227 at #ACMGmtg17 to learn more.
Kate D retweeted
Come check out two top rated @AmbryGenetics posters #227 #228 right next to each other! #ACMGMtg17
Kate D retweeted
Attributes of a high quality test include accuracy and vetted @GeneticCouns luncheon #ACMGMtg17
Kate D retweeted
@rachidkaram RNA studies @AmbryGenetics resulted in reclassification rate of 80%! #ACMGMtg17 teapawt.net/tamijohnston_gc/status…
RNA studies combined with segregation/clinical data for VUS reclassification to benign or pathogenic @rachidkaram @AmbryGenetics #ACMGMtg17
Kate D retweeted
“The important message is that RNA works with cardio, neurological or cancer genes”. @rachidkaram live at #acmgmtg17
Kate D retweeted
“RNA Studies resulted in reclassification of ~80% of variants tested & significant reduction of VUS classifications” @rachidkaram #acmgmtg17
Kate D retweeted
Speaking now at #ACMGmtg17 : Rachid Karam MD, PhD “RNA Studies Improve the Classification of Splicing Variants”
Kate D retweeted
“The ATG Lab performs molecular functional assays that allows us to understand if a VUS is benign or pathogenic” -@rachidkaram #acmgmtg17
Kate D retweeted
“We’ve been successfully performing 2 main assays for 1 yrnow- RNA studies & BRCAPlus Dup. Breakpoint Analysis.” - @rachidkaram #acmgmtg17
Kate D retweeted
RNA studies combined with segregation/clinical data for VUS reclassification to benign or pathogenic @rachidkaram @AmbryGenetics #ACMGMtg17


















